Get the Stockscreener App
2.10
0.96%
0.02
Pre-market:
2.04
-0.06
-2.86%
Annovis Bio Inc stock is traded at $2.10, with a volume of 174.10K.
It is up +0.96% in the last 24 hours and up +1.45% over the past month.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
See More
Previous Close:
$2.08
Open:
$2.08
24h Volume:
174.10K
Relative Volume:
0.30
Market Cap:
$40.92M
Revenue:
-
Net Income/Loss:
$-30.26M
P/E Ratio:
-1.0294
EPS:
-2.04
Net Cash Flow:
$-24.69M
1W Performance:
+2.44%
1M Performance:
+1.45%
6M Performance:
+40.94%
1Y Performance:
-77.37%
1-Day Range:
$2.03
$2.15
1-Week Range:
$2.03
$2.2926
52-Week Range:
$1.11
$9.5274
Annovis Bio Inc Stock (ANVS) Company Profile
Name
Annovis Bio Inc
Sector
Industry
Phone
484-875-3192
Address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Compare ANVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.10 | 48.47M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Downgrade | D. Boral Capital | Buy → Hold |
| Oct-25-24 | Upgrade | Maxim Group | Hold → Buy |
| Dec-29-23 | Initiated | Canaccord Genuity | Buy |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
Annovis Bio Inc Stock (ANVS) Latest News
Is a relief rally coming for Annovis Bio Inc. holdersMarket Risk Report & Low Volatility Stock Recommendations - newser.com
Why Annovis Bio Inc. stock could be next big winnerMarket Performance Report & AI Based Trade Execution Alerts - newser.com
Why retail traders accumulate Annovis Bio Inc. stock2025 Trade Ideas & High Win Rate Trade Tips - newser.com
How Annovis Bio Inc. stock trades during market volatility2025 Macro Impact & Consistent Income Trade Ideas - newser.com
How to track smart money flows in Annovis Bio Inc.Analyst Upgrade & Low Drawdown Investment Strategies - newser.com
Custom watchlist performance reports with Annovis Bio Inc.Market Growth Review & Consistent Profit Trading Strategies - newser.com
Can momentum traders help lift Annovis Bio Inc.Earnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Is Annovis Bio Inc. trending in predictive chart models2025 Market Outlook & Smart Swing Trading Alerts - newser.com
How Annovis Bio Inc. stock compares with top peersRisk Management & Free Community Consensus Stock Picks - newser.com
Can volume confirm reversal in Annovis Bio Inc.Weekly Stock Summary & Expert Verified Movement Alerts - newser.com
Why Annovis Bio Inc. stock stays on buy listsMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Will Annovis Bio Inc. stock see insider accumulationBreakout Watch & Technical Entry and Exit Tips - newser.com
Using data models to predict Annovis Bio Inc. stock movement2025 Performance Recap & Technical Pattern Based Signals - newser.com
How geopolitical risks impact Annovis Bio Inc. stock2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Can Annovis Bio Inc. stock continue upward trend2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Can Annovis Bio Inc. rally from current levelsPortfolio Value Report & Fast Moving Stock Trade Plans - newser.com
What data driven models say about Annovis Bio Inc.’s futureQuarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - newser.com
Tools to assess Annovis Bio Inc.’s risk profileRate Hike & AI Driven Stock Reports - newser.com
Can Annovis Bio Inc. stock hit record highs againJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Will Annovis Bio Inc. stock benefit from automation2025 Analyst Calls & Growth Oriented Trading Recommendations - newser.com
Is Annovis Bio Inc. stock dividend yield sustainable2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Is Annovis Bio Inc. stock attractive for passive investorsProduct Launch & Advanced Technical Signal Analysis - newser.com
Applying Wyckoff theory to Annovis Bio Inc. stockMarket Trend Summary & Daily Profit Maximizing Trade Tips - newser.com
Annovis Bio announces $3.4 million registered direct offering of common stock priced at-the-market under the NYSE rules - MSN
Predicting Annovis Bio Inc. trend using moving averagesPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com
Is Annovis Bio Inc. stock undervalued vs historical averagesMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com
Annovis Bio Inc Stock (ANVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):